The DOI matches its Crossref record; 177 of the 177 references it cites were found in a registry or an index.
IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance
Open accessAbstract
Obesity is characterized by a chronic, low-grade inflammation that contributes to the development of insulin resistance and type 2 diabetes. Cytokines and chemokines produced by immunocompetent cells influence local as well as systemic inflammation and are therefore critical contributors to the pathogenesis of type 2 diabetes. Hence, cytokines that modulate inflammatory responses are emerging as potential targets for intervention and treatment of the metabolic consequences of obesity. The interleukin-1 (IL-1) family of cytokines and receptors are key mediators of innate inflammatory responses and exhibit both pro- and anti-inflammatory functions. During the last decades, mechanistic insights into how the IL-1 family affects the initiation and progression of obesity-induced insulin resistance have increased significantly. Here, we review the current knowledge and understanding, with emphasis on the therapeutic potential of individual members of the IL-1 family of cytokines for improving insulin sensitivity in patients with diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Toll-like receptors: critical proteins linking innate and acquired immunity
Akira, S., Takeda, K., & Kaisho, T. (2001) · Nature Immunology · doi:10.1038/90609 · Cited by 4,777
AMPK: a nutrient and energy sensor that maintains energy homeostasis
Hardie, D. G., Ross, F. A., & Hawley, S. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3311 · Cited by 4,602
Biologic basis for interleukin-1 in disease.
Dinarello, C. (1996) · Blood · doi:10.1182/blood.v87.6.2095.bloodjournal8762095 · Cited by 4,344
Self-citationInflammatory Mechanisms in Obesity
Gregor, M. F., & Hotamisligil, G. S. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101322 · Cited by 3,754
Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466 · cited 3×
“Hence, both IL-36α and IL-36β induce modest IL-8 production from adipocytes, whereas only IL-36α also induces IL-6 production and reduces adipogenesis.”
BackgroundInfluentialSelf-citationKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Cloning of a new cytokine that induces IFN-γ production by T cells
Okamura, H., Tsutsui, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Torigoe, K., Okura, T., Nukada, Y., Hattori, K., et al. (1995) · Nature · doi:10.1038/378088a0 · Cited by 2,600
Cinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
Mechanisms and Functions of Inflammasomes
Lamkanfi, M., & Dixit, V. M. (2014) · Cell · doi:10.1016/j.cell.2014.04.007 · Cited by 2,503
Elective induction versus spontaneous labor after sonographic diagnosis of fetal macrosomia.
Combs, C. A., Singh, N. B., & Khoury, J. C. (1993) · PubMed · Cited by 2,499
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Dinarello, C. A. (2011) · Blood · doi:10.1182/blood-2010-07-273417 · Cited by 2,248
Self-citationLeptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
The interleukin-1 family: back to the future
Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013) · Immunity · doi:10.1016/j.immuni.2013.11.010 · Cited by 1,945 · cited 1×
“The role of IL-38, also ascribed with receptor antagonizing properties, appears to have anti-inflammatory properties largely unknown [21, 22].”
BackgroundInterleukin-1-receptor antagonist in type 2 diabetes mellitus
Larsen, C. M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J. A., Seifert, B., Mandrup-Poulsen, T., & Donath, M. Y. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065213 · Cited by 1,798
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Self-citationFatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs
March, C. J., Mosley, B., Larsen, A., Cerretti, D. P., Braedt, G., Price, V., Gillis, S., Henney, C. S., Kronheim, S. R., Grabstein, K., et al. (1985) · Nature · doi:10.1038/315641a0 · Cited by 1,579
The cellular and signaling networks linking the immune system and metabolism in disease
Osborn, O., & Olefsky, J. M. (2012) · Nature Medicine · doi:10.1038/nm.2627 · Cited by 1,551
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Interleukin-18 Regulates Both Th1 and Th2 Responses
Nakanishi, K., Yoshimoto, T., Tsutsui, H., & Okamura, H. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.423 · Cited by 1,315
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
Metabolism of Inflammation Limited by AMPK and Pseudo-Starvation
O'Neill, L. A. J., & Hardie, D. G. (2013) · Nature · doi:10.1038/nature11862 · Cited by 1,133
Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor
Hannum, C. H., Wilcox, C. J., Arend, W. P., Joslin, F. G., Dripps, D. J., Heimdal, P. L., Armes, L. G., Sommer, A., Eisenberg, S. P., & Thompson, R. C. (1990) · Nature · doi:10.1038/343336a0 · Cited by 1,122
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2017) · Journal of Clinical Investigation · doi:10.1172/jci92172 · Cited by 1,114
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056 · cited 1×
“This finding strengthens the hypothesis that cross-talk between products of resident macrophages and products of adipocytes affect each other and therefore may determine the net inflammatory trait of the adipose tissue and its output function [58]”
BackgroundNucleotide sequence of human monocyte interleukin 1 precursor cDNA.
Auron, P. E., Webb, A. C., Rosenwasser, L. J., Mucci, S. F., Rich, A., Wolff, S. M., & Dinarello, C. A. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.24.7907 · Cited by 1,042
Self-citationGlucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller-Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215318 · Cited by 1,005
Disease-associated functions of IL-33: the new kid in the IL-1 family
Liew, F. Y., Pitman, N. I., & McInnes, I. B. (2010) · Nature Reviews Immunology · doi:10.1038/nri2692 · Cited by 1,003
Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase
Talukdar, S., Oh, D. Y., Bandyopadhyay, G., Li, D., Xu, J., McNelis, J., Lu, M., Li, P., Yan, Q., Zhu, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2885 · Cited by 960
Carey, A. L., Steinberg, G. R., Macaulay, S. L., Thomas, W. G., Holmes, A. G., Ramm, G., Prelovsek, O., Hohnen-Behrens, C., Watt, M. J., James, D. E., et al. (2006) · Diabetes · doi:10.2337/db05-1404 · Cited by 898
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897
Qiu, Y., Nguyen, K. D., Odegaard, J. I., Cui, X., Tian, X., Locksley, R. M., Palmiter, R. D., & Chawla, A. (2014) · Cell · doi:10.1016/j.cell.2014.03.066 · Cited by 865
IL-37 is a fundamental inhibitor of innate immunity
Nold, M. F., Nold-Petry, C. A., Zepp, J. A., Palmer, B. E., Bufler, P., & Dinarello, C. A. (2010) · Nature Immunology · doi:10.1038/ni.1944 · Cited by 849
Self-citationCloning and expression of murine interleukin-1 cDNA in Escherichia coli
Lomedico, P. T., Gubler, U., Hellmann, C. P., Dukovich, M., Giri, J. G., Pan, Y.-C. E., Collier, K., Semionow, R., Chua, A. O., & Mizel, S. B. (1984) · Nature · doi:10.1038/312458a0 · Cited by 816
Ridker, P. M., Thuren, T., Zalewski, A., & Libby, P. (2011) · American Heart Journal · doi:10.1016/j.ahj.2011.06.012 · Cited by 799
A clinical perspective of IL‐1β as the gatekeeper of inflammation
Dinarello, C. A. (2011) · European Journal of Immunology · doi:10.1002/eji.201141550 · Cited by 775
Self-citationYoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S., Okamura, H., Akira, S., & Nakanishi, K. (1998) · PubMed · Cited by 770
Jager, J., Grémeaux, T., Cormont, M., Le Marchand-Brustel, Y., & Tanti, J.-F. (2007) · Endocrinology · doi:10.1210/en.2006-0692 · Cited by 695
Activated Type 2 Innate Lymphoid Cells Regulate Beige Fat Biogenesis
Lee, M.-W., Odegaard, J. I., Mukundan, L., Qiu, Y., Molofsky, A. B., Nussbaum, J. C., Yun, K., Locksley, R. M., & Chawla, A. (2015) · Cell · doi:10.1016/j.cell.2014.12.011 · Cited by 677
Stienstra, R., Joosten, L. A. B., Koenen, T., van Tits, B., van Diepen, J. A., van den Berg, S. A. A., Rensen, P. C. N., Voshol, P. J., Fantuzzi, G., Hijmans, A., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.011 · Cited by 676
Self-citationYoshimoto, T., Takeda, K., Tanaka, T., Ohkusu, K., Kashiwamura, S.-I., Okamura, H., Akira, S., & Nakanishi, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3400 · Cited by 675
IL-33 is a crucial amplifier of innate rather than acquired immunity
Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003059107 · Cited by 652
IL-33 reduces the development of atherosclerosis
Miller, A. M., Xu, D., Asquith, D. L., Denby, L., Li, Y., Sattar, N., Baker, A. H., McInnes, I. B., & Liew, F. Y. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071868 · Cited by 642
SIGIRR, a negative regulator of Toll-like receptor–interleukin 1 receptor signaling
Wald, D., Qin, J., Zhao, Z., Qian, Y., Naramura, M., Tian, L., Towne, J., Sims, J. E., Stark, G. R., & Li, X. (2003) · Nature Immunology · doi:10.1038/ni968 · Cited by 606
Micallef, M. J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Tanimoto, T., Torigoe, K., Fujii, M., Ikeda, M., et al. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260736 · Cited by 597
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Lefrançais, E., Roga, S., Gautier, V., Gonzalez-de-Peredo, A., Monsarrat, B., Girard, J.-P., & Cayrol, C. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115884109 · Cited by 594
Feinstein, R., Kanety, H., Papa, M. Z., Lunenfeld, B., & Karasik, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74276-8 · Cited by 549
The role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Ridker, P. M., Howard, C. P., Walter, V., Everett, B., Libby, P., Hensen, J., & Thuren, T. (2012) · Circulation · doi:10.1161/circulationaha.112.122556 · Cited by 530
Cytotoxicity of Human p I 7 Interleukin-1 for Pancreatic Islets of Langerhans
Bendtzen, K., Mandrup-Poulsen, T., Nerup, J., Nielsen, J. H., Dinarello, C. A., & Svenson, M. (1986) · Science · doi:10.1126/science.3086977 · Cited by 529
Self-citationIL-1α and IL-1β Recruit Different Myeloid Cells and Promote Different Stages of Sterile Inflammation
Rider, P., Carmi, Y., Guttman, O., Braiman, A., Cohen, I., Voronov, E., White, M. R., Dinarello, C. A., & Apte, R. N. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1102048 · Cited by 522
Self-citationDehghan, A., Dupuis, J., Barbalic, M., Bis, J. C., Eiriksdottir, G., Lu, C., Pellikka, N., Wallaschofski, H., Kettunen, J., Henneman, P., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.948570 · Cited by 511
Gerdes, N., Sukhova, G. K., Libby, P., Reynolds, R. S., Young, J. L., & Schönbeck, U. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011022 · Cited by 506
Adaptive immunity in obesity and insulin resistance
Sell, H., Habich, C., & Eckel, J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.114 · Cited by 486
Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection
Alves-Filho, J. C., Sônego, F., Souto, F. O., Freitas, A., Verri, W. A., Auxiliadora-Martins, M., Basile-Filho, A., McKenzie, A. N., Xu, D., Cunha, F. Q., et al. (2010) · Nature Medicine · doi:10.1038/nm.2156 · Cited by 486
Role of IL-33 in inflammation and disease
Miller, A. M. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-22 · Cited by 481
Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance
Netea, M. G., Joosten, L. A. B., Lewis, E., Jensen, D. R., Voshol, P. J., Kullberg, B. J., Tack, C. J., van Krieken, H., Kim, S.-H., Stalenhoef, A. F., et al. (2006) · Nature Medicine · doi:10.1038/nm1415 · Cited by 424
Self-citationInterleukin-18 Enhances Atherosclerosis in Apolipoprotein E −/− Mice Through Release of Interferon-γ
Whitman, S. C., Ravisankar, P., & Daugherty, A. (2002) · Circulation Research · doi:10.1161/hh0202.105292 · Cited by 385
van de Veerdonk, F. L., Stoeckman, A. K., Wu, G., Boeckermann, A. N., Azam, T., Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Hao, R., Kalabokis, V., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121534109 · Cited by 380
Self-citationReduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice
Elhage, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00343-2 · Cited by 373
Identification and Initial Characterization of Four Novel Members of the Interleukin-1 Family
Kumar, S., McDonnell, P. C., Lehr, R., Tierney, L., Tzimas, M. N., Griswold, D. E., Capper, E. A., Tal-Singer, R., Wells, G. I., Doyle, M. L., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.14.10308 · Cited by 364
Glucose-induced β cell production of IL-1β contributes to glucotoxicity in human pancreatic islets
Maedler, K., Sergeev, P., Ris, F., Oberholzer, J., Joller‐Jemelka, H. I., Spinas, G. A., Kaiser, N., Halban, P. A., & Donath, M. Y. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15318 · Cited by 363
Leptin actions on food intake and body temperature are mediated by IL-1
Luheshi, G. N., Gardner, J. D., Rushforth, D. A., Loudon, A. S., & Rothwell, N. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7047 · Cited by 362
IL-37: a new anti-inflammatory cytokine of the IL-1 family
Boraschi, D., Lucchesi, D., Hainzl, S., Leitner, M., Maier, E., Mangelberger, D., Oostingh, G. J., Pfaller, T., Pixner, C., Posselt, G., et al. (2011) · European Cytokine Network · doi:10.1684/ecn.2011.0288 · Cited by 357
Self-citationFour New Members Expand the Interleukin-1 Superfamily
Smith, D. E., Renshaw, B. R., Ketchem, R. R., Kubin, M., Garka, K. E., & Sims, J. E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1169 · Cited by 341
Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity
Donath, M. Y., Dalmas, É., Sauter, N. S., & Böni-Schnetzler, M. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.05.001 · Cited by 338 · cited 1×
“In addition, IL-1β contributes to the development of type 2 diabetes by inhibiting β-cell function and destroying β-cell mass, as reviewed elsewhere [47-50].”
BackgroundIslet Inflammation in Type 2 Diabetes
Donath, M. Y., Schumann, D. M., Faulenbach, M., Ellingsgaard, H., Perren, A., & Ehses, J. A. (2008) · Diabetes Care · doi:10.2337/dc08-s243 · Cited by 334
Role of IL-1β in type 2 diabetes
Dinarello, C. A., Donath, M. Y., & Mandrup-Poulsen, T. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833bf6dc · Cited by 327
Self-citationInflammasome-independent regulation of IL-1-family cytokines
Netea, M. G., van de Veerdonk, F. L., van der Meer, J. W. M., Dinarello, C. A., & Joosten, L. A. B. (2015) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112306 · Cited by 326
Self-citationTowne, J. E., Renshaw, B. R., Douangpanya, J., Lipsky, B. P., Shen, M., Gabel, C. A., & Sims, J. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.267922 · Cited by 326
Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans
Mandrup-Poulsen, T., Bendtzen, K., Nerup, J., Dinarello, C. A., Svenson, M., & Nielsen, J. H. (1986) · Diabetologia · doi:10.1007/bf02427283 · Cited by 324
Self-citationInterleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice
Miller, A. M., Asquith, D. L., Hueber, A. J., Anderson, L. A., Holmes, W. M., McKenzie, A. N., Xu, D., Sattar, N., McInnes, I. B., & Liew, F. Y. (2010) · Circulation Research · doi:10.1161/circresaha.110.218867 · Cited by 324
Long-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes
Lagathu, C., Yvan-Charvet, L., Bastard, J.-P., Maachi, M., Quignard-Boulangé, A., Capeau, J., & Caron, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0335-z · Cited by 321
Chronic adipose tissue inflammation: all immune cells on the stage
Cildir, G., Akıncılar, S. C., & Tergaonkar, V. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.05.001 · Cited by 317
Adipose Tissue Is a Major Source of Interleukin-1 Receptor Antagonist
Juge-Aubry, C. E., Somm, E., Giusti, V., Pernin, A., Chicheportiche, R., Verdumo, C., Rohner-Jeanrenaud, F., Burger, D., Dayer, J.-M., & Meier, C. A. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1104 · Cited by 305
Endotoxin-induced serum factor that stimulates gamma interferon production
Nakamura, K., Okamura, H., Wada, M., Nagata, K., & Tamura, T. (1989) · Infection and Immunity · doi:10.1128/iai.57.2.590-595.1989 · Cited by 299
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Cavelti-Weder, C., Babians-Brunner, A., Keller, C., Stahel, M. A., Kurz-Levin, M., Zayed, H., Solinger, A. M., Mandrup-Poulsen, T., Dinarello, C. A., & Donath, M. Y. (2012) · Diabetes Care · doi:10.2337/dc11-2219 · Cited by 294
Self-citationIL-33 Exacerbates Eosinophil-Mediated Airway Inflammation
Stolarski, B., Kurowska-Stolarska, M., Kewin, P., Xu, D., & Liew, F. Y. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000730 · Cited by 291
Meier, C. A., Bobbioni, E., Gabay, C., Assimacopoulos-Jeannet, F., Golay, A., & Dayer, J.-M. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8351 · Cited by 287
Interleukin-18, more than a Th1 cytokine
Novick, D., Kim, S., Kaplanski, G., & Dinarello, C. A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.014 · Cited by 280
Self-citationCNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK
Watt, M. J., Dzamko, N., Thomas, W. G., Rose-John, S., Ernst, M., Carling, D., Kemp, B. E., Febbraio, M. A., & Steinberg, G. R. (2006) · Nature Medicine · doi:10.1038/nm1383 · Cited by 276
The Inflammasome Puts Obesity in the Danger Zone
Stienstra, R., Tack, C. J., Kanneganti, T.-D., Joosten, L. A. B., & Netea, M. G. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.011 · Cited by 271
Self-citationMoriwaki, Y., Yamamoto, T., Shibutani, Y., Aoki, E., Tsutsumi, Z., Takahashi, S., Okamura, H., Koga, M., Fukuchi, M., & Hada, T. (2003) · Metabolism · doi:10.1053/meta.2003.50096 · Cited by 270
IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy
Verri, W. A., Souto, F. O., Vieira, S. M., Almeida, S. C. L., Fukada, S. Y., Xu, D., Alves-Filho, J. C., Cunha, T. M., Guerrero, A. T. G., Mattos-Guimaraes, R. B., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.122655 · Cited by 263
Weight loss reduces interleukin-18 levels in obese women
Esposito, K., Pontillo, A., Ciotola, M., Di Palo, C., Grella, E., Nicoletti, G., & Giugliano, D. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8781 · Cited by 254 · cited 1×
“Growing interest in the role of IL-1 signaling was present after the observation that circulating IL-18 and IL-1Ra levels were increased in obese subjects and patients with type 2 diabetes, respectively [23, 24], and that adipose tissue is a major source of circulating IL-1Ra levels [25] (Figure 1).”
BackgroundMansuy-Aubert, V., Zhou, Q. L., Xie, X., Gong, Z., Huang, J.-Y., Khan, A. R., Aubert, G., Candelaria, K., Thomas, S., Shin, D.-J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.005 · Cited by 245
The IL-1 Family Member 7b Translocates to the Nucleus and Down-Regulates Proinflammatory Cytokines
Sharma, S., Kulk, N., Nold, M. F., Gräf, R., Kim, S.-H., Reinhardt, D., Dinarello, C. A., & Bufler, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.8.5477 · Cited by 242
Self-citationEsser, N., L’homme, L., De Roover, A., Kohnen, L., Scheen, A. J., Moutschen, M., Piette, J., Legrand-Poels, S., & Paquot, N. (2013) · Diabetologia · doi:10.1007/s00125-013-3023-9 · Cited by 239
Interferon gamma: A master regulator of atherosclerosis
McLaren, J. E., & Ramji, D. P. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.11.003 · Cited by 239
The meta-analysis of genome-wide association studies
Thompson, J. R., Attia, J., & Minelli, C. (2011) · Briefings in Bioinformatics · doi:10.1093/bib/bbr020 · Cited by 236
Annotating genes with potential roles in the immune system: six new members of the IL-1 family
Dunn, E., Sims, J. E., Nicklin, M. J. H., & O'Neill, L. A. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02034-8 · Cited by 233
Iwahana, H., Yanagisawa, K., Ito‐Kosaka, A., Kuroiwa, K., Tago, K., Komatsu, N., Katashima, R., Itakura, M., & Tominaga, S. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00615.x · Cited by 232
Seki, E., Tsutsui, H., Nakano, H., Tsuji, N. M., Hoshino, K., Adachi, O., Adachi, K., Futatsugi, S., Kuida, K., Takeuchi, O., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.4.2651 · Cited by 231
Interleukin-18, a proinflammatory cytokine.
Dinarello, C. A. (2000) · PubMed · Cited by 230
Self-citationLi, S., Neff, C. P., Barber, K., Hong, J., Luo, Y., Azam, T., Palmer, B. E., Fujita, M., Garlanda, C., Mantovani, A., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424626112 · Cited by 230
Self-citationQin, J., Qian, Y., Yao, J., Grace, C., & Li, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501363200 · Cited by 223
IL-37 protects against obesity-induced inflammation and insulin resistance
Ballak, D. B., van Diepen, J. A., Moschen, A. R., Jansen, H. J., Hijmans, A., Groenhof, G.-J., Leenders, F., Bufler, P., Boekschoten, M. V., Müller, M., et al. (2014) · Nature Communications · doi:10.1038/ncomms5711 · Cited by 223
Self-citationKroder, G., Bossenmaier, B., Kellerer, M., Capp, E., Stoyanov, B., Mühlhöfer, A., Berti, L., Horikoshi, H., Ullrich, A., & Häring, H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118569 · Cited by 222
Geriatric cachexia: the role of cytokines
Yeh, S.-S., & Schuster, M. W. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn.70.2.183 · Cited by 219
Cloning and Characterization of IL-1HY2, a Novel Interleukin-1 Family Member
Lin, H., Ho, A. S., Haley-Vicente, D., Zhang, J., Bernal-Fussell, J., Pace, A. M., Hansen, D., Schweighofer, K., Mize, N. K., & Ford, J. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010095200 · Cited by 218
Bulau, A.-M., Nold, M. F., Li, S., Nold-Petry, C. A., Fink, M., Mansell, A., Schwerd, T., Hong, J., Rubartelli, A., Dinarello, C. A., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1324140111 · Cited by 216
Self-citationGao, D., Madi, M., Ding, C., Fok, M., Steele, T., Ford, C., Hunter, L., & Bing, C. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00430.2013 · Cited by 213
Interleukin-33 biology with potential insights into human diseases
Palmer, G., & Gabay, C. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.53 · Cited by 206
IL-18 Augments Perforin-Dependent Cytotoxicity of Liver NK-T Cells
Dao, T., Mehal, W. Z., & Crispe, I. N. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2217 · Cited by 201
McGillicuddy, F. C., Harford, K. A., Reynolds, C. M., Oliver, E., Claessens, M., Mills, K. H. G., & Roche, H. M. (2011) · Diabetes · doi:10.2337/db10-1278 · Cited by 199
Hong, D. S., Hui, D., Bruera, E., Janku, F., Naing, A., Falchook, G. S., Piha-Paul, S., Wheler, J. J., Fu, S., Tsimberidou, A. M., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70155-x · Cited by 199
Escobar-Morreale, H. F., Botella-Carretero, J. I., Villuendas, G., Sancho, J., & San Millán, J. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031365 · Cited by 198
Sauter, N. S., Schulthess, F. T., Galasso, R., Castellani, L. W., & Maedler, K. (2008) · Endocrinology · doi:10.1210/en.2007-1059 · Cited by 198
Suppression of food intake during infection: is interleukin-1 involved?
McCarthy, D., Kluger, M., & Vander, A. (1985) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/42.6.1179 · Cited by 195
Moschen, A. R., Molnar, C., Enrich, B., Geiger, S., Ebenbichler, C. F., & Tilg, H. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00108 · Cited by 184
Sloan-Lancaster, J., Abu-Raddad, E., Polzer, J., Miller, J. W., Scherer, J. C., De Gaetano, A., Berg, J. K., & Landschulz, W. H. (2013) · Diabetes Care · doi:10.2337/dc12-1835 · Cited by 184
IL-33, a recently identified interleukin-1 gene family member, is expressed in human adipocytes
Wood, I. S., Wang, B., & Trayhurn, P. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.04.081 · Cited by 182
Biology of IL-36 cytokines and their role in disease
Gresnigt, M. S., & van de Veerdonk, F. L. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.11.003 · Cited by 177
Mature-Onset Obesity in Interleukin-1 Receptor I Knockout Mice
García, M. C., Wernstedt, I., Berndtsson, A., Enge, M., Bell, M., Hultgren, O., Horn, M., Ahrén, B., Enerback, S., Ohlsson, C., et al. (2006) · Diabetes · doi:10.2337/db05-1304 · Cited by 175
Identification and Gene Organization of Three Novel Members of the IL-1 Family on Human Chromosome 2
Busfield, S. J., Comrack, C. A., Yu, G., Chickering, T. W., Smutko, J. S., Zhou, H., Leiby, K. R., Holmgren, L. M., Gearing, D. P., & Pan, Y. (2000) · Genomics · doi:10.1006/geno.2000.6184 · Cited by 173
van Asseldonk, E. J. P., Stienstra, R., Koenen, T. B., Joosten, L. A. B., Netea, M. G., & Tack, C. J. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2992 · Cited by 173
Self-citationInterleukin-18 controls energy homeostasis by suppressing appetite and feed efficiency
Zorrilla, E. P., Sanchez-Alavez, M., Sugama, S., Brennan, M., Fernandez, R., Bartfai, T., & Conti, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611523104 · Cited by 169
Zeyda, M., Wernly, B., Demyanets, S., Kaun, C., Hämmerle, M., Hantusch, B., Schranz, M., Neuhofer, A., Itariu, B. K., Keck, M., et al. (2013) · International Journal of Obesity · doi:10.1038/ijo.2012.118 · Cited by 164
Interleukin-33 and the function of innate lymphoid cells
Mirchandani, A. S., Salmond, R. J., & Liew, F. Y. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.005 · Cited by 160
Evidence for altered interleukin (IL)‐18 pathway in human heart failure
Mallat, Z., Heymes, C., Corbaz, A., Logeart, D., Alouani, S., Solal, A. C., Seidler, T., Hasenfuss, G. P., Chvatchko, Y., Shah, A. M., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-2426fje · Cited by 160
Rider, P., Carmi, Y., Voronov, E., & Apte, R. N. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.005 · Cited by 155
Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss
Bruun, J. M., Stallknecht, B. M., Helge, J. W., & Richelsen, B. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0206 · Cited by 152
Identification of a Novel Human Cytokine Gene in the Interleukin Gene Cluster on Chromosome 2q12-14
Bensen, J. T., Dawson, P. A., Mychaleckyj, J. C., & Bowden, D. W. (2001) · Journal of Interferon & Cytokine Research · doi:10.1089/107999001753289505 · Cited by 141
Fischer, C. P., Perstrup, L. B., Berntsen, A., Eskildsen, P. C., & Pedersen, B. K. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.07.008 · Cited by 141
The proatherogenic cytokine interleukin-18 is secreted by human adipocytes
Skurk, T., Kolb, H., Müller-Scholze, S., Röhrig, K., Hauner, H., & Herder, C. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01897 · Cited by 135
Tenger, C., Sundborger, A., Jawień, J., & Zhou, X. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000153516.02782.65 · Cited by 130
Interleukin 18 and coronary heart disease: Prospective study and systematic review
Jefferis, B. J. M. H., Papacosta, O., Owen, C. G., Wannamethee, S. G., Humphries, S. E., Woodward, M., LENNON, L. T., Thomson, A. G., Welsh, P. I., Rumley, A., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.03.015 · Cited by 128
IL-33 Exacerbates Autoantibody-Induced Arthritis
Xu, D., Jiang, H., Li, Y., Pushparaj, P. N., Kurowska‐Stolarska, M., Leung, B. P. L., Mu, R., Tay, H. K., McKenzie, A. N. J., McInnes, I. B., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902685 · Cited by 123
Thomassen, E., Bird, T. A., Renshaw, B. R., Kennedy, M. K., & Sims, J. E. (1998) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1998.18.1077 · Cited by 119
Koenen, T. B., Stienstra, R., van Tits, L. J., Joosten, L. A. B., van Velzen, J. F., Hijmans, A., Pol, J. A., van der Vliet, J. A., Netea, M. G., Tack, C. J., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1480 · Cited by 118
Self-citationThe role of AMP-activated protein kinase in regulating white adipose tissue metabolism
Ceddia, R. B. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.06.014 · Cited by 116
Hensen, J., Howard, C. P., Walter, V., & Thuren, T. Y. (2013) · Diabetes & Metabolism · doi:10.1016/j.diabet.2013.07.003 · Cited by 115
Decreased Fat Mass in Interleukin-1 Receptor Antagonist–Deficient Mice
Somm, E., Henrichot, E., Pernin, A., Juge-Aubry, C. E., Muzzin, P., Dayer, J.-M., Nicklin, M. J. H., & Meier, C. A. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3503 · Cited by 114 · cited 1×
“Furthermore IL-1Ra knockout mice, characterized by enhanced IL-1 signaling, are resistant to obesity [76].”
BackgroundHe, J., Usui, I., Ishizuka, K., Kanatani, Y., Hiratani, K., Iwata, M., Bukhari, A., Haruta, T., Sasaoka, T., & Kobayashi, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0107 · Cited by 112
Emerging role of interleukin‐33 in autoimmune diseases
Pei, C., Barbour, M., Fairlie‐Clarke, K. J., Allan, D., Mu, R., & Jiang, H. (2013) · Immunology · doi:10.1111/imm.12174 · Cited by 111
Ohsumi, J., Sakakibara, S., Yamaguchi, J., Miyadai, K., Yoshioka, S., Fujiwara, T., Horikoshi, H., & Serizawa, N. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956951 · Cited by 111
Ohno, T., Morita, H., Arae, K., Matsumoto, K., & Nakae, S. (2012) · Allergy · doi:10.1111/all.12004 · Cited by 111
Liew, F. Y. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200589 · Cited by 109
Juge-Aubry, C. E., Somm, E., Chicheportiche, R., Burger, D., Pernin, A., Pittet-Cuenod, B. M., Quinodoz, P., Giusti, V., Dayer, J., & Meier, C. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031219 · Cited by 108
Negative regulatory receptors of the IL-1 family
Garlanda, C., Riva, F., Bonavita, E., & Mantovani, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.019 · Cited by 103
de Nooijer, R., von der Thüsen, J. H., Verkleij, C. J. N., Kuiper, J., Jukema, J. W., van der Wall, E. E., van Berkel, T. J. C., & Biessen, E. A. L. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000147126.99529.0a · Cited by 99
IL1HY1: A Novel Interleukin-1 Receptor Antagonist Gene
Mulero, J. J., Pace, A. M., Nelken, S. T., Loeb, D. B., Correa, T. R., Drmanac, R., & Ford, J. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1440 · Cited by 99
Dinarello, C. A., & Bufler, P. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.004 · Cited by 97
Self-citationInterleukin-18 Activates Skeletal Muscle AMPK and Reduces Weight Gain and Insulin Resistance in Mice
Lindegaard, B., Matthews, V. B., Brandt, C., Højman, P., Allen, T. L., Estévez, E., Watt, M. J., Bruce, C. R., Mortensen, O. H., Syberg, S., et al. (2013) · Diabetes · doi:10.2337/db12-1095 · Cited by 96
Adipose Tissue Interleukin‐18 mRNA and Plasma Interleukin‐18: Effect of Obesity and Exercise
Leick, L., Lindegaard, B., Stensvold, D., Plomgaard, P., Saltin, B., & Pilegaard, H. (2007) · Obesity · doi:10.1038/oby.2007.528 · Cited by 84
Schernthaner, G.-H., Kopp, H.-P., Kriwanek, S., Krzyzanowska, K., Satler, M., Koppensteiner, R., & Schernthaner, G. (2006) · Obesity Surgery · doi:10.1381/096089206777346763 · Cited by 83
Special aspects of interleukin-33 and the IL-33 receptor complex
Martin, M. U. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.006 · Cited by 83
Functional Polymorphism of IL-1 Alpha and Its Potential Role in Obesity in Humans and Mice
Um, J., Rim, H.-K., Kim, S., Kim, H., & Hong, S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029524 · Cited by 78
Hasan, A., Al-Ghimlas, F., Warsame, S., Alhubail, A., Ahmad, R., Bennakhi, A., Alarouj, M., Behbehani, K., Dehbi, M., & Dermime, S. (2014) · BMC Immunology · doi:10.1186/1471-2172-15-19 · Cited by 73
IL-1 signaling in atherosclerosis: sibling rivalry
Sheedy, F. J., & Moore, K. J. (2013) · Nature Immunology · doi:10.1038/ni.2711 · Cited by 70
Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity
Raymond, N. C., Dysken, M. W., Bettin, K. M., Eckert, E. D., Crow, S. J., Markus, K., & Pomeroy, C. (2000) · International Journal of Eating Disorders · doi:10.1002/1098-108x(200011)28:3<293::aid-eat6>3.0.co;2-f · Cited by 70
Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus
Zilverschoon, G. R. C., Tack, C. J., Joosten, L. A. B., Kullberg, B. J., van der Meer, J. W. M., & Netea, M. G. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.109 · Cited by 69
Self-citationEffect of tumor necrosis factor-alpha on insulin action in cultured rat skeletal muscle cells
Begum, N., & Ragolia, L. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641197 · Cited by 67
Bae, S., Kang, T., Hong, J., Lee, S., Choi, J., Jhun, H., Kwak, A., Hong, K., Kim, E., Jo, S., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.295055 · Cited by 67
Renzo, L. D., Bigioni, M., Del-Gobbo, V., Premrov, M. G., Barbini, U., Lorenzo, N. D., & DELORENZO, A. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.11.002 · Cited by 67
Evans, J., Collins, M., Jennings, C., van der Merwe, L., Söderström, I., Olsson, T., Levitt, N. S., Lambert, E. V., & Goedecke, J. H. (2007) · European Journal of Endocrinology · doi:10.1530/eje-07-0463 · Cited by 57
Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults
Matteini, A. M., Li, J., Lange, E. M., Tanaka, T., Lange, L. A., Tracy, R. P., Wang, Y., Biggs, M. L., Arking, D. E., Fallin, M. D., et al. (2013) · Cytokine · doi:10.1016/j.cyto.2013.10.002 · Cited by 53
Tynan, G. A., Hearnden, C. H. A., Oleszycka, E., Lyons, C. L., Coutts, G., O’Connell, J., Corrigan, M. A., Lynch, L., Campbell, M., Callanan, J. J., et al. (2014) · Diabetes · doi:10.2337/db13-1476 · Cited by 52
Herder, C., Nuotio, M.-L., Shah, S., Blankenberg, S., Brunner, E. J., Carstensen, M., Gieger, C., Grallert, H., Jula, A., Kähönen, M., et al. (2014) · Diabetes · doi:10.2337/db14-0731 · Cited by 46
van Asseldonk, E. J. P., Stienstra, R., Koenen, T. B., van Tits, L. J. H., Joosten, L. A. B., Tack, C. J., & Netea, M. G. (2010) · Obesity · doi:10.1038/oby.2010.55 · Cited by 45
Self-citationAssociation of Interleukin-1β Gene Polymorphism with Body Mass Index in Women
Um, J., Chung, H., Song, M., Shin, H. D., & Kim, H. (2004) · Clinical Chemistry · doi:10.1373/clinchem.2003.025858 · Cited by 44
Associations of the IL‐1F7 gene polymorphisms with rheumatoid arthritis in C hinese H an population
Pei, B., Xu, S., Liu, T., Pan, F., Xu, J., & Ding, C. (2012) · International Journal of Immunogenetics · doi:10.1111/iji.12007 · Cited by 40
Thompson, S. R., Sanders, J., Stephens, J. W., Miller, G. J., & Humphries, S. E. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.015 · Cited by 37
Interleukin-1α neutralisation in patients with cancer
Dinarello, C. A. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70164-0 · Cited by 37
Self-citationThe Inhibitory Effects of Interleukin‐1 on Growth Hormone Action During Catabolic Illness
Cooney, R. N., & Shumate, M. L. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74013-4 · Cited by 31
IL-18 gene polymorphism and metabolic syndrome
Presta, I., Andreozzi, F., Succurro, E., Marini, M. A., Laratta, E., Lauro, R. D., Hribal, M. L., Perticone, F., & Sesti, G. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.10.002 · Cited by 29
Interleukin‐18 Protein Level Is Upregulated in Adipose Tissue of Obese Mice
Membrez, M., Ammon‐Zufferey, C., Philippe, D., Aprikian, O., Monnard, I., Macé, K., & Darimont, C. (2008) · Obesity · doi:10.1038/oby.2008.535 · Cited by 27
Smart, M., Dedoussis, G. V., Yiannakouris, N., Grisoni, M.-L., Ken‐Dror, G., Yannakoulia, M., Papoutsakis, C., Louizou, E., Mantzoros, C. S., Melistas, L., et al. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.12.004 · Cited by 21
Huang, Y., Xu, M., Hong, J., Gu, W., Bi, Y., & Li, X. (2010) · Endocrine · doi:10.1007/s12020-010-9338-0 · Cited by 14
Interleukin-18 enhances glucose uptake in 3T3-L1 adipocytes
Yang, Y., Li, X.-Y., Hong, J., Gu, W., Zhang, Y., Yang, J., Song, H.-D., Chen, J., & Ning, G. (2007) · Endocrine · doi:10.1007/s12020-008-9048-z · Cited by 13
Cited by
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“…human adipocytes decreases insulin-stimulated glucose uptake and lipogenesis (Lagathu et al., 2006; Jager et al., 2007; Fève and Bastard, 2009), reduces glucose transporter type 4 (GLUT4) expression, and inhibits GLUT4 translocation to the plasma membrane (Jager et al., 2007; Ballak et al., 2015).”
BackgroundThe role of interleukin-1 in general pathology
Kaneko, N., Kurata, M., Yamamoto, T., Morikawa, S., & Masumoto, J. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0101-5 · Cited by 617
Interleukin‐18: Biological properties and role in disease pathogenesis
Kaplanski, G. (2018) · Immunological Reviews · doi:10.1111/imr.12616 · Cited by 606
Obesity paradox in cardiovascular disease: where do we stand?
Carbone, S., Canada, J. M., Billingsley, H. E., Siddiqui, M. S., Elagizi, A., & Lavie, C. J. (2019) · Vascular Health and Risk Management · doi:10.2147/vhrm.s168946 · Cited by 365
Targeting the NLRP3 inflammasome in cardiovascular diseases
Toldo, S., Mezzaroma, E., Buckley, L. F., Potere, N., Di Nisio, M., Biondi-Zoccai, G., Van Tassell, B. W., & Abbate, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108053 · Cited by 328
Metadata
- Authors
- Ballak, D. B., Stienstra, R., Tack, C. J., Dinarello, C. A., & van Diepen, J. A.
- Venue
- Cytokine
- Publisher
- Elsevier BV
- Published
- 2015-10
- Volume
- 75
- Issue
- 2
- Pages
- 280-290
- ISSN
- 1043-4666 (ISSN-L)
- OpenAlex
- W925051455
- Cited by
- 255
- References
- 177
- FWCI
- 12.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.